High Times
Home > Boards > US Listed > Biotechs > Advaxis, Inc. (ADXS)

'Just' over 2 billion ....

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
raja48185 Member Profile
 
Followed By 26
Posts 3,131
Boards Moderated 0
Alias Born 05/18/07
160x600 placeholder
Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... Edgar (US Regulatory) - 10/18/2018 5:03:12 PM
Advaxis to Present at the Cantor Fitzgerald Global Healthcare Conference Business Wire - 9/25/2018 8:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/14/2018 10:36:31 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/13/2018 4:32:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/11/2018 4:22:42 PM
Advaxis Announces Closing of Its Public Offering of Common Stock and Warrants Business Wire - 9/11/2018 9:20:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2018 4:42:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 9/10/2018 4:39:45 PM
Advaxis Reports Fiscal 2018 Third Quarter Business Highlights and Financial Results Business Wire - 9/10/2018 4:30:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/10/2018 4:13:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/7/2018 9:49:50 AM
Advaxis Announces Pricing of Its Public Offering of Common Stock and Warrants Business Wire - 9/7/2018 9:25:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/6/2018 5:30:28 PM
Advaxis, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Warrants Business Wire - 9/6/2018 5:08:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/6/2018 10:49:28 AM
Advaxis Licenses ADXS-HER2 to OS Therapies for Evaluation in the Treatment of Osteosarcoma Business Wire - 9/4/2018 8:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/31/2018 6:23:05 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/23/2018 5:31:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/1/2018 4:34:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2018 6:11:48 PM
Advaxis Announces FDA Allowance of IND Application for ADXS-HOT Drug Candidate for Non-Small Cell Lung Cancer Business Wire - 7/30/2018 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/17/2018 4:03:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/13/2018 1:17:55 PM
Advaxis Announces FDA Lifts Clinical Hold on Phase 1/2 Combination Study of Axalimogene Filolisbac with Durvalumab Business Wire - 7/13/2018 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/10/2018 5:22:19 PM
raja48185   Thursday, 12/07/17 07:28:08 PM
Re: blueyedcatch post# 45406
Post # of 83456 
'Just' over 2 billion ....

and you forgot about HER2 which is worth 'just' under 10 billion.


My guess is that Lombardo is spending sleepless nights, his blood pressure rising to dangerous levels, his jealousy unprecedented in the biotech world, as he tosses in bed, thinking about all the potential 'Billionaires' on this board, while he ends up a poor millionaire in comparison.




Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist